Helicobacter Pylori Diagnostics Industry Research Report 2024

Helicobacter Pylori Diagnostics Industry Research Report 2024


Summary

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

According to APO Research, The global Helicobacter Pylori Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Helicobacter Pylori Diagnostics include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Helicobacter Pylori Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori Diagnostics.
The Helicobacter Pylori Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Helicobacter Pylori Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept
Helicobacter Pylori Diagnostics segment by Type

Invasive Techniques
Non-invasive Techniques
Helicobacter Pylori Diagnostics Segment by Application

Hospitals and Clinics
Diagnostic Laboratories
Others
Helicobacter Pylori Diagnostics Segment by Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Helicobacter Pylori Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Helicobacter Pylori Diagnostics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Invasive Techniques
2.2.3 Non-invasive Techniques
2.3 Helicobacter Pylori Diagnostics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Hospitals and Clinics
2.3.3 Diagnostic Laboratories
2.3.4 Others
2.4 Assumptions and Limitations
3 Helicobacter Pylori Diagnostics Breakdown Data by Type
3.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Type (2019-2024)
3.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Type (2025-2030)
4 Helicobacter Pylori Diagnostics Breakdown Data by Application
4.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Application (2019-2024)
4.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Helicobacter Pylori Diagnostics Market Perspective (2019-2030)
5.2 Global Helicobacter Pylori Diagnostics Growth Trends by Region
5.2.1 Global Helicobacter Pylori Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Helicobacter Pylori Diagnostics Historic Market Size by Region (2019-2024)
5.2.3 Helicobacter Pylori Diagnostics Forecasted Market Size by Region (2025-2030)
5.3 Helicobacter Pylori Diagnostics Market Dynamics
5.3.1 Helicobacter Pylori Diagnostics Industry Trends
5.3.2 Helicobacter Pylori Diagnostics Market Drivers
5.3.3 Helicobacter Pylori Diagnostics Market Challenges
5.3.4 Helicobacter Pylori Diagnostics Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue
6.1.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue (2019-2024)
6.1.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2019-2024)
6.2 Global Helicobacter Pylori Diagnostics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Helicobacter Pylori Diagnostics Head office and Area Served
6.4 Global Helicobacter Pylori Diagnostics Players, Product Type & Application
6.5 Global Helicobacter Pylori Diagnostics Players, Date of Enter into This Industry
6.6 Global Helicobacter Pylori Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Helicobacter Pylori Diagnostics Market Size (2019-2030)
7.2 North America Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
7.4 North America Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Helicobacter Pylori Diagnostics Market Size (2019-2030)
8.2 Europe Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
8.4 Europe Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Helicobacter Pylori Diagnostics Market Size (2019-2030)
9.2 Asia-Pacific Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
9.4 Asia-Pacific Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 Latin America
10.1 Latin America Helicobacter Pylori Diagnostics Market Size (2019-2030)
10.2 Latin America Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
10.4 Latin America Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Helicobacter Pylori Diagnostics Market Size (2019-2030)
11.2 Middle East & Africa Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
11.4 Middle East & Africa Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 Players Profiled
12.1 Sekisui Diagnostics
12.1.1 Sekisui Diagnostics Company Information
12.1.2 Sekisui Diagnostics Business Overview
12.1.3 Sekisui Diagnostics Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
12.1.5 Sekisui Diagnostics Recent Developments
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Information
12.2.2 F. Hoffmann-La Roche Business Overview
12.2.3 F. Hoffmann-La Roche Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
12.2.5 F. Hoffmann-La Roche Recent Developments
12.3 Medline Industries
12.3.1 Medline Industries Company Information
12.3.2 Medline Industries Business Overview
12.3.3 Medline Industries Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
12.3.5 Medline Industries Recent Developments
12.4 Meridian Bioscience
12.4.1 Meridian Bioscience Company Information
12.4.2 Meridian Bioscience Business Overview
12.4.3 Meridian Bioscience Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
12.4.5 Meridian Bioscience Recent Developments
12.5 Bio-Rad Laboratories
12.5.1 Bio-Rad Laboratories Company Information
12.5.2 Bio-Rad Laboratories Business Overview
12.5.3 Bio-Rad Laboratories Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
12.5.5 Bio-Rad Laboratories Recent Developments
12.6 Thermo Fisher Scientific
12.6.1 Thermo Fisher Scientific Company Information
12.6.2 Thermo Fisher Scientific Business Overview
12.6.3 Thermo Fisher Scientific Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
12.6.5 Thermo Fisher Scientific Recent Developments
12.7 Alpha Laboratories
12.7.1 Alpha Laboratories Company Information
12.7.2 Alpha Laboratories Business Overview
12.7.3 Alpha Laboratories Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
12.7.5 Alpha Laboratories Recent Developments
12.8 EKF Diagnostics
12.8.1 EKF Diagnostics Company Information
12.8.2 EKF Diagnostics Business Overview
12.8.3 EKF Diagnostics Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
12.8.5 EKF Diagnostics Recent Developments
12.9 Quidel
12.9.1 Quidel Company Information
12.9.2 Quidel Business Overview
12.9.3 Quidel Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
12.9.5 Quidel Recent Developments
12.10 Halyard Health
12.10.1 Halyard Health Company Information
12.10.2 Halyard Health Business Overview
12.10.3 Halyard Health Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
12.10.5 Halyard Health Recent Developments
12.11 Cardinal Health
12.11.1 Cardinal Health Company Information
12.11.2 Cardinal Health Business Overview
12.11.3 Cardinal Health Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
12.11.5 Cardinal Health Recent Developments
12.12 Beckman Coulter
12.12.1 Beckman Coulter Company Information
12.12.2 Beckman Coulter Business Overview
12.12.3 Beckman Coulter Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
12.12.5 Beckman Coulter Recent Developments
12.13 Agilent Technologies
12.13.1 Agilent Technologies Company Information
12.13.2 Agilent Technologies Business Overview
12.13.3 Agilent Technologies Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
12.13.5 Agilent Technologies Recent Developments
12.14 Coris BioConcept
12.14.1 Coris BioConcept Company Information
12.14.2 Coris BioConcept Business Overview
12.14.3 Coris BioConcept Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
12.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
12.14.5 Coris BioConcept Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings